A patient reported outcome measure in renal cell caner patients
- Conditions
- Health Condition 1: C642- Malignant neoplasm of left kidney,except renal pelvisHealth Condition 2: C641- Malignant neoplasm of right kidney, except renal pelvisHealth Condition 3: C649- Malignant neoplasm of unspecifiedkidney, except renal pelvisHealth Condition 4: C659- Malignant neoplasm of unspecifiedrenal pelvis
- Registration Number
- CTRI/2021/10/037418
- Lead Sponsor
- Innsbruck Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria for the patients:
1.Patients with a diagnosis of renal cell cancer (irrespective of treatment or follow up status)
2.Patients who are18 years of age or above
3.Patients with no other concurrent malignancies
4.Patients with no cognitive impairment
5.Patients willing to provide written informed consent for the study
Inclusion criteria for HCPs:
1.Consultants from any of the specialist disciplines of medical oncology, surgical oncology, other (radiation oncology) treating patients with RCC
2.Consultants of either gender
3.Willing to participate and provide a written informed consent
Exclusion criteria for patients:
1.None. Anyone fulfilling the inclusion criteria will be eligible for the study.
Exclusion criteria for HCPs:
1.None. Anyone fulfilling the inclusion criteria will be eligible for the study
2.Patients not willing to provide written informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Is to develop a provisional questionnaire ready for pre-testing in <br/ ><br>Phase III as per the module development guidelines of the EORTC Quality of Life Group (QLG)Timepoint: baseline
- Secondary Outcome Measures
Name Time Method oneTimepoint: Not applicable